Cargando…
Therapeutic use of calpeptin in COVID-19 infection
This perspective considers the benefits of the potential future use of the cell permeant calpain inhibitor, calpeptin, as a drug to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Recent work has reported calpeptin’s capacity to inhibit entry of the virus into cells. El...
Autores principales: | Inal, Jameel, Paizuldaeva, Ainura, Terziu, Esmeralda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594985/ https://www.ncbi.nlm.nih.gov/pubmed/36268783 http://dx.doi.org/10.1042/CS20220638 |
Ejemplares similares
-
Casting a wide NET: an update on uncontrolled NETosis in response to COVID-19 infection
por: Taylor, Erin B.
Publicado: (2022) -
Covid-19: the renin–angiotensin system imbalance hypothesis
por: Lanza, Katharina, et al.
Publicado: (2020) -
Comparative Host–Pathogen Interaction Analyses of SARS-CoV2 and Aspergillus fumigatus, and Pathogenesis of COVID-19-Associated Aspergillosis
por: Khan, Abdul Arif, et al.
Publicado: (2021) -
NAD(+)-consuming enzymes in immune defense against viral infection
por: Shang, Jialin, et al.
Publicado: (2021) -
Impact of Gut Bacteria on the Infection and Transmission of Pathogenic Arboviruses by Biting Midges and Mosquitoes
por: Möhlmann, Tim W. R., et al.
Publicado: (2020)